Emergent BioSolutions Inc. (EBS) NYSE

8.07

-0.37(-4.38%)

Updated at June 05 04:00PM

Currency In USD

Valuation

Market Cap661.26M
Enterprise Value1.03B
P/E Ratio-48.7
PEG Ratio0.41
Price/Sales Ratio0.62
Price/Book Ratio0.8
Enterprise/Revenue1.23
Enterprise/EBITDA4.98

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.01
Operating Margin0.11

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue742.9M
Revenue/Share13.04
Gross Profit350.6M
EBITDA208.5M
Net Income52.6M
Diluted EPS0.93

Balance Sheet

Total Cash160.3M
Total Cash/Share3.09
Total Debt573.6M
Total Debt/Equity1.1
Current Ratio4.29
Book Value Per Share10.08

Price History

52-Week Change21.72
52-Week High14.06
52-Week Low5.62
Moving Average 50 Days8.4
Moving Average 200 Days9.75

Statistics

Average Volume772,547
Shares Outstanding51.6M
% Held by Institutions80.41

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A